151
Participants
Start Date
November 30, 2002
Primary Completion Date
July 31, 2006
Study Completion Date
July 31, 2006
somatropin
Novo Nordisk Investigational Site, Matosinhos Municipality
Novo Nordisk Investigational Site, Prague
Novo Nordisk Investigational Site, Prague
Novo Nordisk Investigational Site, Santiago de Compostela
Novo Nordisk Investigational Site, Granada
Novo Nordisk Investigational Site, Madrid
Novo Nordisk Investigational Site, Madrid
Novo Nordisk Investigational Site, Madrid
Novo Nordisk Investigational Site, Málaga
Novo Nordisk Investigational Site, Haifa
Novo Nordisk Investigational Site, Usti N. Labem
Novo Nordisk Investigational Site, Wuppertal
Novo Nordisk Investigational Site, Valencia
Novo Nordisk Investigational Site, Krefeld
Novo Nordisk Investigational Site, Petah Tikva
Novo Nordisk Investigational Site, Brno
Novo Nordisk Investigational Site, Heidelberg
Novo Nordisk Investigational Site, Kuopio
Novo Nordisk Investigational Site, Rehovot
Novo Nordisk Investigational Site, Olomouc
Novo Nordisk Investigational Site, Beersheba
Novo Nordisk Investigational Site, Oulu
Novo Nordisk Investigational Site, Gotha
Novo Nordisk Investigational Site, Prague
Novo Nordisk Investigational Site, Helsinki
Novo Nordisk Investigational Site, Leipzig
Novo Nordisk Investigational Site, Gdansk
Novo Nordisk Investigational Site, Krakow
Novo Nordisk Investigational Site, Warsaw
Novo Nordisk Investigational Site, Coimbra
Novo Nordisk Investigational Site, Porto
Novo Nordisk Investigational Site, Vila Nova de Gaia
Novo Nordisk Investigational Site, Barcelona
Novo Nordisk Investigational Site, Esplugues Llobregat
Novo Nordisk Investigational Site, Helsingborg
Novo Nordisk Investigational Site, Örebro
Novo Nordisk Investigational Site, Stockholm
Lead Sponsor
Novo Nordisk A/S
INDUSTRY